These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 11163132)

  • 21. Mutations causing neurodegenerative tauopathies.
    Goedert M; Jakes R
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):240-50. PubMed ID: 15615642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tau proteins harboring neurodegeneration-linked mutations impair kinesin translocation in vitro.
    Yu D; LaPointe NE; Guzman E; Pessino V; Wilson L; Feinstein SC; Valentine MT
    J Alzheimers Dis; 2014; 39(2):301-14. PubMed ID: 24150109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Their relevance for understanding the neurogenerative process.
    Goedert M; Ghetti B; Spillantini MG
    Ann N Y Acad Sci; 2000; 920():74-83. PubMed ID: 11193179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death.
    Feinstein SC; Wilson L
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):268-79. PubMed ID: 15615645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells.
    Mack TG; Dayanandan R; Van Slegtenhorst M; Whone A; Hutton M; Lovestone S; Anderton BH
    Neuroscience; 2001; 108(4):701-12. PubMed ID: 11738505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain.
    Lim F; Hernández F; Lucas JJ; Gómez-Ramos P; Morán MA; Avila J
    Mol Cell Neurosci; 2001 Dec; 18(6):702-14. PubMed ID: 11749044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tau gene mutations and their effects.
    Goedert M
    Mov Disord; 2005 Aug; 20 Suppl 12():S45-52. PubMed ID: 16092090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three distinct axonal transport rates for tau, tubulin, and other microtubule-associated proteins: evidence for dynamic interactions of tau with microtubules in vivo.
    Mercken M; Fischer I; Kosik KS; Nixon RA
    J Neurosci; 1995 Dec; 15(12):8259-67. PubMed ID: 8613759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transgenic zebrafish model of neurodegeneration.
    Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
    J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tau protein and neurodegeneration.
    Kosik KS
    Mol Neurobiol; 1990; 4(3-4):171-9. PubMed ID: 2135393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tau stabilizes microtubules by binding at the interface between tubulin heterodimers.
    Kadavath H; Hofele RV; Biernat J; Kumar S; Tepper K; Urlaub H; Mandelkow E; Zweckstetter M
    Proc Natl Acad Sci U S A; 2015 Jun; 112(24):7501-6. PubMed ID: 26034266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative analysis of MAP-mediated regulation of microtubule dynamic instability in vitro focus on Tau.
    Kiris E; Ventimiglia D; Feinstein SC
    Methods Cell Biol; 2010; 95():481-503. PubMed ID: 20466149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
    Kowalska A
    Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases.
    Schraen-Maschke S; Dhaenens CM; Delacourte A; Sablonnière B
    Neurobiol Dis; 2004 Apr; 15(3):449-60. PubMed ID: 15056452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Missense and splice site mutations in tau associated with FTDP-17: multiple pathogenic mechanisms.
    Hutton M
    Neurology; 2001 Jun; 56(11 Suppl 4):S21-5. PubMed ID: 11402146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microtubule Dysfunction: A Common Feature of Neurodegenerative Diseases.
    Sferra A; Nicita F; Bertini E
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A role for FKBP52 in Tau protein function.
    Chambraud B; Sardin E; Giustiniani J; Dounane O; Schumacher M; Goedert M; Baulieu EE
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2658-63. PubMed ID: 20133804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tau story: from frontotemporal dementia to other tauopathies].
    Buée L; Hamdane M; Delobel P; Sambo AV; Bégard S; Ghestem A; Sergeant N; Delacourte A
    J Soc Biol; 2002; 196(1):103-8. PubMed ID: 12134624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17.
    Clark LN; Poorkaj P; Wszolek Z; Geschwind DH; Nasreddine ZS; Miller B; Li D; Payami H; Awert F; Markopoulou K; Andreadis A; D'Souza I; Lee VM; Reed L; Trojanowski JQ; Zhukareva V; Bird T; Schellenberg G; Wilhelmsen KC
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13103-7. PubMed ID: 9789048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered microtubule organization in small-calibre axons of mice lacking tau protein.
    Harada A; Oguchi K; Okabe S; Kuno J; Terada S; Ohshima T; Sato-Yoshitake R; Takei Y; Noda T; Hirokawa N
    Nature; 1994 Jun; 369(6480):488-91. PubMed ID: 8202139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.